+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755



Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755



Journal of Antibiotics 39(4): 564-568



Frophenicinol, S-2-(3-hydroxy-4-hydroxymethylphenyl)glycine, prolonged the survival period of mice implanted with Meth A fibrosarcoma or Lewis lung carcinoma. The effect was observed in the mice when the primary tumor was removed by amputation. At autopsy, metastasized tumors were found in all dead mice but no tumor foci were detected in any of the mice still alive at the time of sacrifice. Moreover, forphenicinol suppressed the growth of subcutaneously implanted adenocarcinoma 755. When combined with surgical resection of primary tumors, forphenicinol administration both before and after resection suppressed the growth of recurrent tumors and prolonged the survival period of the mice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004768698

Download citation: RISBibTeXText

PMID: 3710915

DOI: 10.7164/antibiotics.39.564


Related references

Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections. Journal of Antibiotics 35(8): 1049-1054, 1982

Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4. Journal of Biological Response Modifiers 6(1): 35-43, 1987

Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms. Journal of Antibiotics 40(4): 547-554, 1987

Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Cancer Treatment Reports 69(3): 285-291, 1985

Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice. Journal of the National Cancer Institute 65(2): 391-396, 1980

Effect of forphenicinol a small molecular immunomodifier on growth of a syngeneic guinea pig hepatoma and a study of its mechanisms. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 659, 1986

Antitumor effect of combination therapy of proflamin with cryosurgery of meth-A fibrosarcoma in BALB/c mice. International Journal of Medicinal Mushrooms 7(4): 539-545, 2005

Effect of forphenicinol on the production of lipopolysaccharide-induced interferon and tumor necrosis factor and on the growth of Meth A fibrosarcoma in mice. Journal of Biological Response Modifiers 6(1): 28-34, 1987

Antitumor activity of calcium in combination with antitumor agents against Lewis lung carcinoma. In Vivo 3(3): 147-149, 1989

Antitumor activity of ascorbic acid in combination with antitumor agents against Lewis lung carcinoma. In Vivo 2(3-4): 247-252, 1988

Changes in the immunological parameters after a single dose of forphenicinol, a new small molecular immunomodifier. Tohoku Journal of Experimental Medicine 146(4): 419-427, 1985

Effect of combination immunochemotherapy with an organogermanium compound, Ge-132, and antitumor agents on C57BL/6 mice bearing Lewis lung carcinoma (3LL). Gan to Kagaku Ryoho. Cancer & ChemoTherapy 13(8): 2588-2593, 1986

Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma. Cancer Research 40(12): 4617-4621, 1980

Inhibitory effect of dihydroaustrasulfone alcohol on the migration of human non-small cell lung carcinoma A549 cells and the antitumor effect on a Lewis lung carcinoma-bearing tumor model in C57BL/6J mice. Marine Drugs 12(1): 196-213, 2014

Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma. Cancer Immunology, ImmunoTherapy 18(2): 82-86, 1984